Barriers and facilitators to the use of medications for opioid use disorder: a rapid review

K Mackey, S Veazie, J Anderson, D Bourne… - Journal of general …, 2020 - Springer
Background Despite evidence that medications to treat opioid use disorder (OUD) are
effective, most people who could benefit from this treatment do not receive it. This rapid …

[HTML][HTML] Improving access to evidence-based medical treatment for opioid use disorder: strategies to address key barriers within the treatment system

BK Madras, NJ Ahmad, J Wen, JS Sharfstein - NAM perspectives, 2020 - ncbi.nlm.nih.gov
Even though evidence-based treatment for opioid use disorders (OUD) is effective, almost
four in five Americans with OUD do not receive any form of treatment. The gap in access to …

[HTML][HTML] Medication-Assisted Treatment for Opioid Use Disorder

National Academies of Sciences, Engineering, and … - 2018 - ncbi.nlm.nih.gov
On October 30 and 31, 2018, the Committee on Medication-Assisted Treatment (MAT) for
Opioid Use Disorder (OUD) held a 1.5-day workshop in Washington, DC. To support the …

Buprenorphine management in the perioperative period: educational review and recommendations from a multisociety expert panel

L Kohan, S Potru, AM Barreveld, M Sprintz… - Regional Anesthesia & …, 2021 - rapm.bmj.com
Background The past two decades have witnessed an epidemic of opioid use disorder
(OUD) in the USA, resulting in catastrophic loss of life secondary to opioid overdoses …

Pharmacy-related buprenorphine access barriers: an audit of pharmacies in counties with a high opioid overdose burden

NJ Kazerouni, AN Irwin, XA Levander, J Geddes… - Drug and alcohol …, 2021 - Elsevier
Background Pharmacies sometimes restrict access to buprenorphine-naloxone
(buprenorphine) for individuals with opioid use disorder. The objective of this study was to …

Self-reported treatment need and barriers to care for adults with opioid use disorder: the US national survey on drug use and health, 2015 to 2019

J Saini, B Johnson, DM Qato - American journal of …, 2022 - ajph.aphapublications.org
Objectives. To explore barriers to care and characteristics associated with respondent-
reported perceived need for opioid use disorder (OUD) treatment and National Survey on …

Prescribing practices of nurse practitioners and physician assistants waivered to prescribe buprenorphine and the barriers they experience prescribing buprenorphine

CHA Andrilla, KC Jones… - The Journal of Rural …, 2020 - Wiley Online Library
Abstract Background In 2016, the Comprehensive Addiction Recovery Act permitted nurse
practitioners (NPs) and physician assistants (PAs) to obtain a waiver to prescribe …

Buprenorphine Treatment By Primary Care Providers, Psychiatrists, Addiction Specialists, And Others: Trends in buprenorphine treatment by prescriber specialty …

M Olfson, V Zhang, M Schoenbaum, M King - Health Affairs, 2020 - healthaffairs.org
Substantial increases in opioid-related morbidity and mortality have motivated the
implementation of federal policies to expand the buprenorphine prescribing capacity of …

Comparison between buprenorphine provider availability and opioid deaths among US counties

CW Jones, Z Christman, CM Smith… - Journal of substance …, 2018 - Elsevier
Background Buprenorphine is an effective medication for the treatment of opioid addiction,
but current barriers to buprenorphine access limit treatment availability for many patients …

Preliminary effectiveness of online opioid overdose and naloxone administration training and impact of naloxone possession on opioid use

ML Sisson, A Azuero, KR Chichester… - Drug and alcohol …, 2023 - Elsevier
Background Despite the demonstrated value of opioid overdose education and naloxone
distribution (OEND) programs, uptake and utilization remains low. Accessibility to OEND is …